We are live on
!
Find out more
Tudor Investment Corp Portfolio holdings
AUM
$53.9B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
-1.47%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$19.5B
AUM Growth
+$3.8B
(+24%)
Cap. Flow
+$4.18B
Cap. Flow
% of AUM
21.4%
Top 10 Holdings %
Top 10 Hldgs %
34.26%
Holding
2,929
New
786
Increased
755
Reduced
667
Closed
671
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
AbCellera Biologics
ABCL
$3.25B
| $700K | ﹤0.01% |
236,649
+145,915
| +161% | +$552K |
|
1652
Franco-Nevada
FNV
$45B
| $700K | ﹤0.01% |
+5,904
| New | +$717K |
|
1653
Zebra Technologies
ZBRA
$17.8B
| $696K | ﹤0.01% |
+2,254
| New | +$685K |
|
1654
Outset Medical
OM
$78.4M
| $695K | ﹤0.01% |
12,039
+295
| +3% | +$14.5K |
|
1655
Frontier Group Holdings
ULCC
$1.56B
| $695K | ﹤0.01% |
+140,941
| New | +$845K |
|
1656
Applied Industrial Technologies
AIT
$13.3B
| $694K | ﹤0.01% |
+3,576
| New | +$682K |
|
1657
First Interstate BancSystem
FIBK
$3.73B
| $693K | ﹤0.01% |
24,967
-92,990
| -79% | -$2.46M |
|
1658
PUT
Delta Air Lines
DAL
$59.8B
| $693K | ﹤0.01% |
14,600
-18,400
| -56% | -$916K |
|
1659
PUT
Tenet Healthcare
THC
$21.4B
| $692K | ﹤0.01% |
5,200
+1,300
| +33% | +$156K |
|
|
ORLA
1660
DELISTED
Orla Mining
ORLA
| $690K | ﹤0.01% |
+179,596
| New | +$720K |
|
1661
PUT
Nice
NICE
$6.02B
| $688K | ﹤0.01% |
4,000
-8,300
| -67% | -$1.71M |
|
1662
T. Rowe Price
TROW
$23.5B
| $688K | ﹤0.01% |
5,965
+2,069
| +53% | +$238K |
|
1663
CALL
Southern Company
SO
$107B
| $675K | ﹤0.01% |
+8,700
| New | +$659K |
|
1664
Miller Industries
MLR
$640M
| $675K | ﹤0.01% |
12,262
+4,549
| +59% | +$250K |
|
1665
Bunge Global
BG
$21.8B
| $674K | ﹤0.01% |
+6,313
| New | +$662K |
|
1666
ARK Genomic Revolution ETF
ARKG
$1.74B
| $673K | ﹤0.01% |
+28,682
| New | +$724K |
|
1667
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $673K | ﹤0.01% |
5,952
-78,526
| -93% | -$8.27M |
|
1668
Liberty Live Group Series C
LLYVK
$9.94B
| $673K | ﹤0.01% |
17,575
| – | – |
|
1669
JPMorgan Chase
JPM
$970B
| $671K | ﹤0.01% |
+3,317
| New | +$648K |
|
1670
PUT
Suncor Energy
SU
$77.7B
| $671K | ﹤0.01% |
+17,600
| New | +$680K |
|
1671
CALL
CME Group
CME
$95.8B
| $668K | ﹤0.01% |
3,400
-5,400
| -61% | -$1.12M |
|
1672
CareTrust REIT
CTRE
$9.1B
| $667K | ﹤0.01% |
+26,593
| New | +$659K |
|
1673
PUT
Teladoc Health
TDOC
$1.25B
| $663K | ﹤0.01% |
+67,800
| New | +$827K |
|
1674
Mastercard
MA
$497B
| $663K | ﹤0.01% |
+1,503
| New | +$685K |
|
|
SLCA
1675
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $661K | ﹤0.01% |
+42,789
| New | +$630K |
|
Similar funds
SCP
NAMI
RIM
Tudor Investment Corp's Q2 2024 Portfolio in Review
As of Q2 2024, Tudor Investment Corp held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Tudor Investment Corp deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Tudor Investment Corp's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Tudor Investment Corp added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Tudor Investment Corp's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Tudor Investment Corp fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Tudor Investment Corp's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Tudor Investment Corp opened 786 new positions and closed 671 in Q2 2024.
- Tudor Investment Corp's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.